« Back
Home /
Wedelolactone

Wedelolactone

Item no.	TMO-T3384-25mg
Manufacturer	TargetMol
CASRN	524-12-9
Amount	25 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 20 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,9942
Citations	1. Nehybova T, et al. Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. Int J Mol Sci. 2017 Mar 29;18(4).
Smiles	COc1cc(O)c2c3oc4cc(O)c(O)cc4c3c(=O)oc2c1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	IKK Inhibitor II
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Caspase\|\|\|Apoptosis\|\|\|Lipoxygenase\|\|\|NF-κB
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	314.25
Description	Wedelolactone (IKK Inhibitor II) inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.
Pathways	Proteases/Proteasome\|\|\|Apoptosis\|\|\|NF-κB\|\|\|Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3384-25mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question